Safety of drugs used for the treatment of Crohn’s disease

Long-term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy

(2018) W. J. Sandborn et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience

(2018) P. Wils et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn’s Disease With up to 6 Years of Follow-Up in the Pyramid Registry

(2018) Geert D’Haens et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study

(2018) Marco Vincenzo Lenti et al.   DIGESTIVE AND LIVER DISEASE

Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development

(2018) Rebecca Matro et al.   GASTROENTEROLOGY

What Is the Risk of Progressive Multifocal Leukoencephalopathy in Patients With Ulcerative Colitis or Crohn’s Disease Treated With Vedolizumab?

(2018) Timothy Card et al.   INFLAMMATORY BOWEL DISEASES

Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease—A Multicenter Retrospective European Study

(2018) Uri Kopylov et al.   INFLAMMATORY BOWEL DISEASES

P140 Physician attitudes about the use of immunosuppressive therapy for inflammatory bowel disease in the elderly

(2018) W P W Chan et al.   Journal of Crohns & Colitis

Respiratory Tract Infections in Patients With Inflammatory Bowel Disease: Safety Analyses From Vedolizumab Clinical Trials

(2018) Brian G Feagan et al.   Journal of Crohns & Colitis

Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease

(2018) Stefan Schreiber et al.   JOURNAL OF GASTROENTEROLOGY

Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation

(2018) Dana Duricova et al.   INFLAMMATORY BOWEL DISEASES

Thiopurines Dosed to a Therapeutic 6-Thioguanine Level in Combination with Adalimumab Are More Effective Than Subtherapeutic Thiopurine-based Combination Therapy or Adalimumab Monotherapy During Induction and Maintenance in Patients with Long-standing Crohnʼs Disease

(2017) Viraj C. Kariyawasam et al.   INFLAMMATORY BOWEL DISEASES

Evaluation of the Quality of Semen and Sexual Function in Men with Inflammatory Bowel Disease

(2017) Paz Valer et al.   INFLAMMATORY BOWEL DISEASES

Vedolizumab Is Safe and Effective in Elderly Patients with Inflammatory Bowel Disease

(2017) Udayakumar Navaneethan et al.   INFLAMMATORY BOWEL DISEASES

Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease

(2017) Magali Lemaitre et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Vedolizumab Levels in Breast Milk of Nursing Mothers With Inflammatory Bowel Disease

(2017) Adi Lahat et al.   Journal of Crohns & Colitis

Vedolizumab in IBD–Lessons From Real-world Experience; A Systematic Review and Pooled Analysis

(2017) Tal Engel et al.   Journal of Crohns & Colitis

Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia

(2017) Natalie Ertz-Archambault et al.   JAMA Oncology

The Real-World Effectiveness and Safety of Vedolizumab for Moderate–Severe Crohn’s Disease: Results From the US VICTORY Consortium

(2016) Parambir S Dulai et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Therapeutic drug monitoring of anti-tumour necrosis factor-α agents in inflammatory bowel disease

(2016) Nikola Mitrev et al.   Expert Opinion On Drug Safety

A safety assessment of anti-tumor necrosis factor alpha therapy for treatment of Crohn’s disease

(2016) Konstantinos Papamichael et al.   Expert Opinion On Drug Safety

Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection

(2016) Mette Julsgaard et al.   GASTROENTEROLOGY

The safety of vedolizumab for ulcerative colitis and Crohn's disease

(2016) Jean-Frédéric Colombel et al.   GUT

Use of Methotrexate in the Treatment of Inflammatory Bowel Diseases

(2016) Hans H. Herfarth et al.   INFLAMMATORY BOWEL DISEASES

Ustekinumab therapy for Crohn's disease during pregnancy: a case report and review of the literature

(2016) X. Cortes et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

(2016) Brian G. Feagan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

(2015) A. Bourrier et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Effectiveness and Safety of Immunomodulators With Anti–Tumor Necrosis Factor Therapy in Crohn’s Disease

(2015) Mark T. Osterman et al.   Clinical Gastroenterology and Hepatology

379 Expression of NOTCH Signaling Molecules in Barrett's Associated Adenocarcinoma

(2015) Dan Li et al.   GASTROENTEROLOGY

Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease

(2015) Marieke J.H. Coenen et al.   GASTROENTEROLOGY

Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease

(2015) Niels Vande Casteele et al.   GASTROENTEROLOGY

Progressive multifocal leukoencephalopathy: current treatment options and future perspectives

(2015) Dejan Pavlovic et al.   Therapeutic Advances in Neurological Disorders

Optimizing the use of biological therapy in patients with inflammatory bowel disease

(2015) A. C. Moss   Gastroenterology Report

865 PIANO: A 1000 Patient Prospective Registry of Pregnancy Outcomes in Women With IBD Exposed to Immunomodulators and Biologic Therapy

(2015) Uma Mahadevan et al.   GASTROENTEROLOGY

Early Use of Thiopurines or Methotrexate Reduces Major Abdominal and Perianal Surgery in Crohnʼs Disease

(2014) Viraj C. Kariyawasam et al.   INFLAMMATORY BOWEL DISEASES

Stopping, Continuing, or Restarting Immunomodulators and Biologics When an Infection or Malignancy Develops

(2014) Jason M. Swoger et al.   INFLAMMATORY BOWEL DISEASES

A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia

(2014) Suk-Kyun Yang et al.   NATURE GENETICS

HLA-DQA1–HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants

(2014) Graham A Heap et al.   NATURE GENETICS

Adverse events in IBD: to stop or continue immune suppressant and biologic treatment

(2014) Leon P McLean et al.   Expert Review of Gastroenterology & Hepatology

Systematic review: macrophage activation syndrome in inflammatory bowel disease

(2013) W. Fries et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Safety of Anti-TNF Agents During Pregnancy and Breastfeeding in Women With Inflammatory Bowel Disease

(2013) Javier P Gisbert et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Safety of Thiopurines and Anti-TNF-α Drugs During Pregnancy in Patients With Inflammatory Bowel Disease

(2013) M J Casanova et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Risk of Lymphoma in Patients With Ulcerative Colitis Treated With Thiopurines: A Nationwide Retrospective Cohort Study

(2013) Nabeel Khan et al.   GASTROENTEROLOGY

Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis

(2013) Remo Panaccione et al.   GASTROENTEROLOGY

Increased Risk of Malignancy With Adalimumab Combination Therapy, Compared With Monotherapy, for Crohn's Disease

(2013) Mark T. Osterman et al.   GASTROENTEROLOGY

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

(2013) William J. Sandborn et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Case of Therapy-Related Myeloid Neoplasm in a Patient with Crohn’s Disease Treated with Azathioprine

(2012) François Mullier et al.   ACTA HAEMATOLOGICA

Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry

(2012) Gary R Lichtenstein et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Systematic Review and Meta-analysis on the Effects of Thiopurines on Birth Outcomes from Female and Male Patients with Inflammatory Bowel Disease

(2012) Mona Akbari et al.   INFLAMMATORY BOWEL DISEASES

Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease

(2012) William J. Sandborn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

(2012) Gary Bloomgren et al.   NEW ENGLAND JOURNAL OF MEDICINE

Methotrexate-induced pneumonitis in Crohn's disease. Case report and review of the literature

(2012) Nadia D'Andrea et al.   MULTIDISCIPLINARY RESPIRATORY MEDICINE

Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease

(2011) Laurent Peyrin–Biroulet et al.   GASTROENTEROLOGY

The Safety and Tolerability of Methotrexate for Treating Patients With Crohnʼs Disease

(2011) Nilesh Chande et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Effects of TNF antagonists on sperm characteristics in patients with spondyloarthritis

(2010) P. M. Villiger et al.   ANNALS OF THE RHEUMATIC DISEASES

Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti–Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease

(2010) Mario Cottone et al.   Clinical Gastroenterology and Hepatology

A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease

(2010) David S. Kotlyar et al.   Clinical Gastroenterology and Hepatology

Thiopurine therapy in inflammatory bowel disease patients: Analyses of two 8-year intercept cohorts

(2010) B. Jharap et al.   INFLAMMATORY BOWEL DISEASES

Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's Disease

(2010) Kuldeep Cheent et al.   Journal of Crohns & Colitis

Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding

(2010) Sieglinde Angelberger et al.   Journal of Crohns & Colitis

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

(2010) Jean Frédéric Colombel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis

(2009) Corey A. Siegel et al.   Clinical Gastroenterology and Hepatology

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

(2009) Laurent Beaugerie et al.   LANCET

Azathioprine treatment during lactation

(2008) L. A. CHRISTENSEN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Thiopurine-Induced Myelotoxicity in Patients With Inflammatory Bowel Disease: A Review

(2008) Javier P. Gisbert et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials

(2008) Laurent Peyrin–Biroulet et al.   Clinical Gastroenterology and Hepatology

Thiopurine hepatotoxicity in inflammatory bowel disease: the role for adding allopurinol

(2008) Rupert WL Leong et al.   Expert Opinion On Drug Safety

Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study

(2008) H Fidder et al.   GUT